Sightline U3O8 : SightlineU3O8 Report: Details a Looming Spike in the Price of Uranium
TORONTO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- SightlineU3O8 , a leading nuclear industry research organization, today published an analysis of the key factors governing the market price of uranium. The data summarized in an article titled "Uranium's Time is Now! " indicates that numerous factors are converging to create a potential near-term turnaround in the market price of the commodity.
The full article can be read at www.sightlineu3o8.com/2017/11/now
"What many do not realize is that new reactor builds over the past 6 years have pushed uranium demand back to pre-Fukushima levels. Today, for the first time in over 35 years, nuclear power generation is rapidly rising while the production of nuclear fuel is swiftly falling, signaling a tipping point for investors."
The analysis discusses the factors that created excess inventory in the uranium fuel cycle as well as the variables that have been at work to now reverse that situation.
SightlineU3O8 is a nuclear industry research organization reporting through a monthly newsletter and supporting website created and maintained to provide uranium investors and industry stakeholders with a single source of insight into the ongoing factors that directly affect uranium prices.
For further information please contact:
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Appian Corporation23.5.2018 13:31 | pressemeddelelse
Addiko Bank Implements Digital Banking Solutions on Appian
VITEC23.5.2018 10:01 | pressemeddelelse
VITEC to Showcase High-Quality, Low-Bandwidth Tactical Video Solutions at Eurosatory 2018
Jobindex A/S23.5.2018 08:33 | pressemeddelelse
1. kvartal 2018: Jobindex er kommet godt fra start
Gallene Sciences PVT. LTD22.5.2018 23:02 | pressemeddelelse
MyoGen: Leaders of an Anabolic Revolution
XBiotech, Inc22.5.2018 14:01 | pressemeddelelse
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis
PubMatic, Inc.22.5.2018 14:01 | pressemeddelelse
Apps Lead the Charge as Mobile Advertising Continues to Grow Worldwide
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum